APPL1 _ DIP13A
- Known as:
- APPL1 _ DIP13A
- Catalog number:
- GTX25640
- Product Quantity:
- 100 µg
- Category:
- -
- Supplier:
- ACR
- Gene target:
- APPL1 _ DIP13A
Related genes to: APPL1 _ DIP13A
- Gene:
- APPL1 NIH gene
- Name:
- adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
- Previous symbol:
- -
- Synonyms:
- APPL
- Chromosome:
- 3p14.3
- Locus Type:
- gene with protein product
- Date approved:
- 2007-01-26
- Date modifiied:
- 2016-03-14
Related products to: APPL1 _ DIP13A
Adapter protein containing PH domain, PTB domain and leucine zipper motif 1,APPL,APPL1,DCC-interacting protein 13-alpha,DIP13A,Dip13-alpha,Homo sapiens,Human,KIAA1428Adapter protein containing PH domain, PTB domain and leucine zipper motif 1,Appl1,DCC-interacting protein 13-alpha,Dip13a,Dip13-alpha,Kiaa1428,Mouse,Mus musculusanti-APPL1anti-APPL1anti-APPL1anti-APPL1 / APPL (aa111-160)anti-APPL1 type: Primary antibodies host: RabbitAnti-Mouse APPL1 (KIAA1428), Rabbit PolyclonalAnti-Mouse APPL1 (KIAA1428), Rabbit PolyclonalAntibodies: APPL1 HOST: Goat Clonality: pAbAPP Gene amyloid beta (A4) precursor proteinAPPL1Appl1APPL1APPL1 DIP13A antibody Ab host: Goat Related articles to: APPL1 _ DIP13A
- Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder with increasing morbidity and mortality, and current pharmacotherapies are limited by adverse effects and an inability to reverse the underlying metabolic decline. Tussilago farfara L., a traditional Chinese medicine historically used for diabetes treatment, contains the highly abundant sesquiterpenoid GDD with favorable anti-diabetic properties. - Source: PubMed
Publication date: 2026/08/11
Zheng HaoZhao Ya-RuDeng Xian-YanHuang Dan-YuQiu Fang-QiongYan ChangLi Shu-YingChen JingSong Wan-BinLv Hui-QingWu Ri-HuiLin LigenGan Li-She - Necroptosis is implicated in the pathogenesis of various inflammatory diseases, including periodontitis. This study aimed to investigate the molecular mechanisms underlying necroptosis in gingival fibroblasts (GFs) and to evaluate the therapeutic potential of AdipoAI, a novel adiponectin receptor agonist, administered locally, along with its regulatory effect on necroptosis. - Source: PubMed
Publication date: 2026/07/27
Qiu WeiDing DianShao JunHuang YuxuanChen ZehaoGuo RuimingZhao HuaxuanWu HongleFang Fuchun - Gastrointestinal (GI) involvement in systemic sclerosis (SSc) affects up to 90% of patients and is a major driver of morbidity and mortality. Despite its clinical importance, GI disease in SSc is highly heterogeneous, with upper and lower GI manifestations representing distinct phenotypic extremes whose underlying immunologic basis remains poorly defined. - Source: PubMed
Publication date: 2026/05/21
McMahan Zsuzsanna HPuttapaka SrinivasHulett TylerShah Ami AFaheem KathrynHu ShaohuiSonmez GamzeRamos PedroKulkarni Subhash - Here we investigate the status of the adiponectin-PEPITEM pathway in early, treatment naive rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and the therapeutic efficacy of PEPITEM administration in preclinical models. - Source: PubMed
Publication date: 2026/04/13
Wahid MussaratKemble SamuelAbudu OladimejiSaviano AnellaMahony ChristopherLewis Jonathan WNicholson Thomas ASchettino AnnaMarigliano NoemiFrost KathrynBegum JenefaUrbanowski Alyssa MLimo MarionJha RakeshJarquin Sandra MartinezPezhman LalehDegan Abbie E AAnderson Amy ESmith Charlotte GBatki ArmaitiAdams HollyCaso FrancescoScarpa RaffaeleMcInnes IainSiebert StefanPratt Arthur GFiler AndrewRaza KarimCroft Adam PChimen Myriamde Cogan FelicityRainger G EdIqbal Asif JMaione FrancescoMcGettrick Helen M - - Source: PubMed
Cellular Longevity Oxidative Medicine And